跳至主要内容
临床试验/NCT06056271
NCT06056271招募中不适用

Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation

Volta Medical4 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2024年3月19日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Volta Medical
入组人数
400
试验地点
4
主要终点
Primary Clinical Efficacy Outcome

研究概览

简要总结

Observational, multi-center, clinical device registry for US patients with a primary goal to observe the clinical outcomes in patients who are mapped with Volta Medical's VX1 or AF-Xplorer systems during AF ablation procedures.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 21 years of age or older who is:
  • indicated for AF ablation or
  • Who has received an AF-ablation with the past 24 months where VX1 was used or
  • Patients are receiving or received a catheter ablation procedure for AF according to current guidelines
  • Patients must be able and willing to provide written informed consent to participate in the clinical trial

排除标准

  • Patients not indicated or were not indicated for catheter ablation according to current guidelines
  • Patients with AF secondary to an obvious reversible cause
  • Patients who are or may potentially be pregnant
  • Enrollment in an investigational study evaluating another non-VX1 investigational device, biologic, or drug

结局指标

主要结局

Primary Clinical Efficacy Outcome

时间窗: 12 and 24 months

Percentage of subjects free from clinically significant AF or atrial arrhythmia recurrences, after one or multiple ablation procedures, stratified by type of clinical workflow and ablation history.

次要结局

未报告次要终点

研究者

发起方
Volta Medical
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验